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268 Serum vitamin D levels do not accurately predict parathyroid
hormone levels in children with CF
A.J. Fall1, J.M. Kirk2. 1Royal Hospital for Sick Children Edinburgh, Respiratory,
Edinburgh, United Kingdom; 2Royal Hospital for Sick Children Edinburgh,
Biochemistry, Edinburgh, United Kingdom
Objectives: To assess the relationship between measured vitamin D and parathyroid
hormone (PTH) levels in children with CF, and to assess the clinical ability of a
low vitamin D level to predict a raised PTH.
Methods: 65 paired 25OH vitamin D (25OHD) and PTH levels from children
attending for annual review in a single year were analysed. The correlation
between 25OHD and PTH was ascertained. Regression analysis was used to assess
the relationship between 25OHD and PTH. Comparative statistics were used to
assess the differences in PTH level between those children regarded as Vitamin D
sufﬁcient, insufﬁcient or deﬁcient.
Results:
• 25OHD results were normally distributed (mean = 52.4 nmol/l, SD = 23.7).
• Only 5 of all PTH results (median 2.95 pmol/l, interquartile range 2.04) were
above the upper limit of our laboratory’s quoted reference standard.
• Although there was a weak negative correlation between 25OHD and PTH
(r = −0.18), a wide range of PTH values (mostly within the laboratory reference
range) was observed at all 25OHD levels.
• Regression analysis showed no meaningful functional relationship between
25OHD and PTH (R2 = 0.03).
• Whilst there was a tendency toward lower PTH values with higher 25OHD levels,
this was not statistically signiﬁcant between the groups of children regarded as
Vitamin D sufﬁcient, insufﬁcient or deﬁcient.
Conclusions:
• Almost all children with CF in our population had PTH levels within the
laboratory reference range.
• The small numbers of elevated PTH levels were not conﬁned to the vitamin D
deﬁcient children.
• No reliable inference regarding any likely PTH response to a given 25OHD can
be made from a single 25OHD result.
269 Oral vitamin D2 supplementation in children with cystic
ﬁbrosis makes a relatively small contribution to total serum
25OH vitamin D levels
A.J. Fall1, J. Chawla1. 1Royal Hospital for Sick Children Edinburgh, Respiratory,
Edinburgh, United Kingdom
Background: European guidelines recommend that vitamin D levels are measured
annually and supplements increased if necessary [1]. In health most of the body’s
vitamin D3 is produced endogenously following skin exposure to UV radiation.
Oral supplementation may be with vitamin D2 or D3.
Objectives: (1) To deﬁne the levels of total 25OH vitamin D (25OHD) measured at
clinical review in vitamin D supplemented children attending a specialist CF clinic
in Scotland. (2) To assess the relative contribution of vitamin D2 to total measured
25OHD in those children receiving vitamin D2 supplements.
Method: Total serum 25OHD, 25OHD2 and 25OHD3 assay results (nmol/l) from 58
serum specimens were analysed retrospectively. The type of vitamin D supplement
taken by each patient was ascertained.
Results: The measured total 25OHD was normally distributed, and with no differ-
ence between groups, in those children taking D3 supplements (n = 27; mean 58.3
sd 23.8) and in those taking D2 supplements (n = 31; mean 55.8 sd 26.2). In children
taking vitamin D2 supplements the distribution of 25OHD2 levels was positively
skewed (median 13; range 0−81). 25OHD2 was completely undetectable in 42% of
samples from Vitamin D2 supplemented children. In only 6 instances did 25OHD2
contribute to >50% of total 25OHD.
Conclusion: The contribution to total measured vitamin D made by oral supplemen-
tation with vitamin D2 in this population may be overestimated if separate assays
of 25OHD2 and 25OHD3 are not performed. This ﬁnding may be due to non-
adherence to prescribed medication and an argument for the routine measurement
of 25OHD2 as an indicator of adherence could be made.
Reference(s)
[1] J Cyst Fibros 2005; 4: 7−26.
270 Factors associated with vitamin K deﬁciency in adults with cystic
ﬁbrosis
A. Ochota1, S. Pandya1, M. Walshaw1. 1Liverpool Heart and Chest Hospital,
Liverpool, United Kingdom
Objectives: Although Vitamin K is important for haemostasis and bone health, its
deﬁciency is often overlooked in CF. We wished to assess the vitamin K status of
our CF patients, and also look at proposed clinical factors for its deﬁciency.
Methods: We measured PIVKA II (protein induced in vitamin K absence II)
as a marker of vitamin K status and compared it with pancreatic insufﬁciency,
use of antibiotics, CF related liver disease and bowel resection, with additional
consideration of lung function and nutritional state, in 56 CF patients (median age
25 years [IQR 14]) using parametric and non-parametric tests as appropriate.
Results: Twenty-two patients (39%) had PIVKA II 0.2AU/ml, indicating sub-
clinical vitamin K deﬁciency. Those infected with transmissible Pseudomonas
aeruginosa or Burkholderia cepacia complex were more likely to be deﬁcient
(Fisher’s exact test p< 0.03), but there was no association with other clinical
parameters.
Conclusions: The study shows that a signiﬁcant proportion of adult CF patients
have subclinical vitamin K deﬁciency. It is not possible to identify those at risk
on the basis of most clinical CF abnormalities, but the association with the more
pathogenic lung infections merits further study. For best clinical practice, a formal
assessment of vitamin K status is required in individual patients.
271 Iodine deﬁciency and subclinical hyperthyroidism are common
in cystic ﬁbrosis patients
L. Naehrlich1, H.-G. Do¨rr2, A. Bagheri-Behrouzi1, M. Rauch2. 1Justus-Liebig-
University Giessen, Department of Pediatrics, Giessen, Germany; 2University
of Erlangen-Nuremberg, Department of Paediatrics and Adolescent Medicine,
Erlangen, Germany
Background: Disorders of thyroid function were sporadically described in children
with cystic ﬁbrosis (CF) and in CF transmembrane regulator protein knockout
animals. Reports on iodine status in CF individuals are lacking in the literature.
Patients and Methods: We investigated 129 children, adolescents and adults with
CF (mean age 14.6±9.5 years; range 0.4–43.4 years), who are living in the northern
part of Bavaria/Germany. Malnutrition (28.7%) and lung function (normal FEV1 in
57.1% of cases) was reported. Urinary iodine excretion, TSH, fT4 were measured
and set in relation to population-based, age-adjusted reference ranges.
Results: Subclinical hypothyroidism (normal fT4, elevated TSH) was found in
11.6% and iodine deﬁciency in 83.7%. No correlation was found with age, BMI,
status of malnutrition and lung function. In no patient with elevated TSH antibodies
against thyroid peroxidase and human thyroglobulin or an abnormal ultrasound of
the thyyroid could be detected.
Conclusions: Dramatic iodine deﬁciency was found in our cohort of CF patients
in comparison with healthy children living in the same area. This result can
cause subclinical hypothyroidism. Therefore, an individual iodine supplementation
programme is necessary and should be started immediately.
